181 related articles for article (PubMed ID: 35122179)
1. Dynamic Changes of NCR
Cai J; Lu H; Su Z; Mi L; Xu S; Xue Z
Inflammation; 2022 Apr; 45(2):497-508. PubMed ID: 35122179
[TBL] [Abstract][Full Text] [Related]
2. [The number of ILC3 and their related cytokines IL-17 and IL-22 increase in lungs of mice with bronchopulmonary dysplasia].
Cai J; Lu H; Su Z; Wang Q; Mi L; Xu S; Xue Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Oct; 36(10):865-870. PubMed ID: 33148379
[TBL] [Abstract][Full Text] [Related]
3. ILC2 regulates hyperoxia-induced lung injury via an enhanced Th17 cell response in the BPD mouse model.
Zhu Y; Mi L; Lu H; Ju H; Hao X; Xu S
BMC Pulm Med; 2023 May; 23(1):188. PubMed ID: 37254088
[TBL] [Abstract][Full Text] [Related]
4. Tissue-Resident Type 2 Innate Lymphoid Cells Arrest Alveolarization in Bronchopulmonary Dysplasia.
Mi L; Zhu S; Cai J; Xu S; Xue Z; Lu H
J Immunol Res; 2020; 2020():8050186. PubMed ID: 33178840
[TBL] [Abstract][Full Text] [Related]
5. NCR negative group 3 innate lymphoid cell (NCR
Chu S; Ma L; Yang X; Xiao B; Liang Y; Zheng S; Li L
Immun Inflamm Dis; 2023 Mar; 11(3):e816. PubMed ID: 36988250
[TBL] [Abstract][Full Text] [Related]
6. [Changes and significance of type 2 innate lymphoid cells and their related factors in bronchopulmonary dysplasia].
Wang QW; Zhu Y; Wang QX; Lu HY
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Feb; 25(2):179-185. PubMed ID: 36854695
[TBL] [Abstract][Full Text] [Related]
7. Type 2 innate lymphoid cell-derived amphiregulin regulates type II alveolar epithelial cell transdifferentiation in a mouse model of bronchopulmonary dysplasia.
Yao HC; Zhu Y; Lu HY; Ju HM; Xu SQ; Qiao Y; Wei SJ
Int Immunopharmacol; 2023 Sep; 122():110672. PubMed ID: 37480752
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia.
Nold MF; Mangan NE; Rudloff I; Cho SX; Shariatian N; Samarasinghe TD; Skuza EM; Pedersen J; Veldman A; Berger PJ; Nold-Petry CA
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14384-9. PubMed ID: 23946428
[TBL] [Abstract][Full Text] [Related]
9. ILC2 influence the differentiation of alveolar type II epithelial cells in bronchopulmonary dysplasia mice.
Lu HY; Wang MY; Zhu SX; Ju HM; Xu SQ; Qiao Y; Wei SJ; Su ZL
J Leukoc Biol; 2023 Nov; 114(6):604-614. PubMed ID: 37647586
[TBL] [Abstract][Full Text] [Related]
10. Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia.
Rudloff I; Cho SX; Bui CB; McLean C; Veldman A; Berger PJ; Nold MF; Nold-Petry CA
J Cell Mol Med; 2017 Jun; 21(6):1128-1138. PubMed ID: 27957795
[TBL] [Abstract][Full Text] [Related]
11. NCR
Liu Y; Song Y; Lin D; Lei L; Mei Y; Jin Z; Gong H; Zhu Y; Hu B; Zhang Y; Zhao L; Teo HY; Qiu J; Jiang W; Dong C; Wu D; Huang Y; Liu H
EBioMedicine; 2019 Mar; 41():333-344. PubMed ID: 30827928
[TBL] [Abstract][Full Text] [Related]
12. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
[TBL] [Abstract][Full Text] [Related]
13. Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua.
Vacca P; Vitale C; Munari E; Cassatella MA; Mingari MC; Moretta L
Front Immunol; 2018; 9():1897. PubMed ID: 30154799
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and Functional Plasticity of Murine Intestinal NKp46+ Group 3 Innate Lymphoid Cells.
Verrier T; Satoh-Takayama N; Serafini N; Marie S; Di Santo JP; Vosshenrich CA
J Immunol; 2016 Jun; 196(11):4731-8. PubMed ID: 27183613
[TBL] [Abstract][Full Text] [Related]
15. Placental IL-10 dysregulation and association with bronchopulmonary dysplasia risk.
McGowan EC; Kostadinov S; McLean K; Gotsch F; Venturini D; Romero R; Laptook AR; Sharma S
Pediatr Res; 2009 Oct; 66(4):455-60. PubMed ID: 19581835
[TBL] [Abstract][Full Text] [Related]
16. Complementarity and redundancy of IL-22-producing innate lymphoid cells.
Rankin LC; Girard-Madoux MJ; Seillet C; Mielke LA; Kerdiles Y; Fenis A; Wieduwild E; Putoczki T; Mondot S; Lantz O; Demon D; Papenfuss AT; Smyth GK; Lamkanfi M; Carotta S; Renauld JC; Shi W; Carpentier S; Soos T; Arendt C; Ugolini S; Huntington ND; Belz GT; Vivier E
Nat Immunol; 2016 Feb; 17(2):179-86. PubMed ID: 26595889
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of inflammatory lung injury in the neonate: lessons from a transgenic mouse model of bronchopulmonary dysplasia.
Bry K; Hogmalm A; Bäckström E
Semin Perinatol; 2010 Jun; 34(3):211-21. PubMed ID: 20494738
[TBL] [Abstract][Full Text] [Related]
18. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients.
Teunissen MBM; Munneke JM; Bernink JH; Spuls PI; Res PCM; Te Velde A; Cheuk S; Brouwer MWD; Menting SP; Eidsmo L; Spits H; Hazenberg MD; Mjösberg J
J Invest Dermatol; 2014 Sep; 134(9):2351-2360. PubMed ID: 24658504
[TBL] [Abstract][Full Text] [Related]
19. Cell Division Cycle 2 Protects Neonatal Rats Against Hyperoxia-Induced Bronchopulmonary Dysplasia.
Li Z; Chen Y; Li W; Yan F
Yonsei Med J; 2020 Aug; 61(8):679-688. PubMed ID: 32734731
[TBL] [Abstract][Full Text] [Related]
20. Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection.
Van Maele L; Carnoy C; Cayet D; Ivanov S; Porte R; Deruy E; Chabalgoity JA; Renauld JC; Eberl G; Benecke AG; Trottein F; Faveeuw C; Sirard JC
J Infect Dis; 2014 Aug; 210(3):493-503. PubMed ID: 24577508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
